Literature DB >> 33398434

Perivascular macrophages produce type I collagen around cerebral small vessels under prolonged hypertension in rats.

Takeshi Inagaki1, Ken Fujiwara2,3, Yoshiaki Shinohara2, Morio Azuma4, Reiji Yamazaki2, Kiyomi Mashima5, Atsushi Sakamoto6, Takashi Yashiro2, Nobuhiko Ohno7.   

Abstract

Hypertension leads to structural remodeling of cerebral blood vessels, which has been implicated in the pathophysiology of cerebrovascular diseases. The remodeling and progression of arteriolosclerosis under hypertension involve fibrosis along with the production of type I collagen around cerebral arterioles. However, the source and regulatory mechanisms of this collagen production remain elusive. In this study, we examined if perivascular macrophages (PVMs) are involved in collagen production around cerebral small vessels in hypertensive SHRSP/Izm rats. Immunoreactivity for type I collagen around cerebral small vessels in 12-week-old hypertensive rats tended to higher than those in 4-week-old hypertensive and 12-week-old control rats. In ultrastructural analyses using transmission electron microscopy, the substantial deposition of collagen fibers could be observed in the intercellular spaces around PVMs near the arterioles of rats with prolonged hypertension. In situ hybridization analyses revealed that cells positive for mRNA of Col1a1, which comprises type I collagen, were observed near cerebral small vessels. The Col1a1-positive cells around cerebral small vessels were colocalized with immunoreactivity for CD206, a marker for PVMs, but not with those for glial fibrillary acidic protein or desmin, markers for other perivascular cells such as astrocytes and vascular smooth muscle cells. These results demonstrated that enhanced production of type I collagen is observed around cerebral small vessels in rats with prolonged hypertension and Col1a1 is expressed by PVMs, and support the concept that PVMs are involved in collagen production and vascular fibrosis under hypertensive conditions.

Entities:  

Keywords:  Cerebral arteriolosclerosis; Hypertension; Perivascular macrophages; Type I collagen

Year:  2021        PMID: 33398434     DOI: 10.1007/s00418-020-01948-9

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  35 in total

Review 1.  Macrophage subsets in atherosclerosis.

Authors:  Giulia Chinetti-Gbaguidi; Sophie Colin; Bart Staels
Journal:  Nat Rev Cardiol       Date:  2014-11-04       Impact factor: 32.419

Review 2.  Functional structure and composition of the extracellular matrix.

Authors:  Fred T Bosman; Ivan Stamenkovic
Journal:  J Pathol       Date:  2003-07       Impact factor: 7.996

Review 3.  Mechanisms of lung aging.

Authors:  Christina Brandenberger; Christian Mühlfeld
Journal:  Cell Tissue Res       Date:  2016-10-14       Impact factor: 5.249

4.  Turnover of rat brain perivascular cells.

Authors:  I Bechmann; E Kwidzinski; A D Kovac; E Simbürger; T Horvath; U Gimsa; U Dirnagl; J Priller; R Nitsch
Journal:  Exp Neurol       Date:  2001-04       Impact factor: 5.330

Review 5.  Cellular and molecular mechanisms of kidney fibrosis.

Authors:  Sonja Djudjaj; Peter Boor
Journal:  Mol Aspects Med       Date:  2018-06-22

6.  Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer.

Authors:  Thomas R Cox; Janine T Erler
Journal:  Dis Model Mech       Date:  2011-02-14       Impact factor: 5.758

7.  Maintenance of the Extracellular Matrix in Rat Anterior Pituitary Gland: Identification of Cells Expressing Tissue Inhibitors of Metalloproteinases.

Authors:  Morio Azuma; Alimuddin Tofrizal; Rita Maliza; Khongorzul Batchuluun; Dini Ramadhani; Rahimi Syaidah; Takehiro Tsukada; Ken Fujiwara; Motoshi Kikuchi; Kotaro Horiguchi; Takashi Yashiro
Journal:  Acta Histochem Cytochem       Date:  2015-11-19       Impact factor: 1.938

Review 8.  Rational modulation of the innate immune system for neuroprotection in ischemic stroke.

Authors:  Diana Amantea; Giuseppe Micieli; Cristina Tassorelli; María I Cuartero; Iván Ballesteros; Michelangelo Certo; María A Moro; Ignacio Lizasoain; Giacinto Bagetta
Journal:  Front Neurosci       Date:  2015-04-29       Impact factor: 4.677

9.  MHC matching fails to prevent long-term rejection of iPSC-derived neurons in non-human primates.

Authors:  Romina Aron Badin; Aurore Bugi; Susannah Williams; Marta Vadori; Marie Michael; Caroline Jan; Alberto Nassi; Sophie Lecourtois; Antoine Blancher; Emanuele Cozzi; Philippe Hantraye; Anselme L Perrier
Journal:  Nat Commun       Date:  2019-09-25       Impact factor: 14.919

10.  TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1.

Authors:  Marina Cardellini; Rossella Menghini; Eugenio Martelli; Viviana Casagrande; Arianna Marino; Stefano Rizza; Ottavia Porzio; Alessandro Mauriello; Anna Solini; Arnaldo Ippoliti; Renato Lauro; Franco Folli; Massimo Federici
Journal:  Diabetes       Date:  2009-07-06       Impact factor: 9.461

View more
  4 in total

1.  In focus in HCB.

Authors:  Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2021-04-13       Impact factor: 4.304

2.  Dark Rearing in the Visual Critical Period Causes Structural Changes in Myelinated Axons in the Adult Mouse Visual Pathway.

Authors:  Yasuyuki Osanai; Batpurev Battulga; Reiji Yamazaki; Tom Kouki; Megumi Yatabe; Hiroaki Mizukami; Kenta Kobayashi; Yoshiaki Shinohara; Yumiko Yoshimura; Nobuhiko Ohno
Journal:  Neurochem Res       Date:  2022-08-06       Impact factor: 4.414

Review 3.  The pleiotropic mode and molecular mechanism of macrophages in promoting tumor progression and metastasis.

Authors:  Xingxing Zhang; Wenxiu Bai; Lisha Hu; Hualan Ha; Yuelin Du; Wei Xiong; Hongbo Wang; Panfeng Shang
Journal:  Clin Transl Oncol       Date:  2022-09-07       Impact factor: 3.340

Review 4.  Immune Modulatory Properties of Collagen in Cancer.

Authors:  Anne Mette Askehøj Rømer; Marie-Louise Thorseth; Daniel Hargbøl Madsen
Journal:  Front Immunol       Date:  2021-12-08       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.